florence Thibaut

Prof. florence Thibaut

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2017 in The World Journal of Biological Psychiatry
Verified
Journal Article
Open access
PLPiotr Lewczuk
Piotr Lewczuk
RPRiederer Peter
Riederer Peter
OEO'Bryant Sid E
O'Bryant Sid E
VMVerbeek Marcel M
Verbeek Marcel M
DBDubois Bruno
Dubois Bruno
JKJohannes Konrhuber
Johannes Konrhuber
In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes now the opportunity to extend and update the original paper. New concepts of Alzheimer's disease (AD) and the conceptual interactions between AD and dementia due to AD were developed, resulting in two sets for diagnostic/research criteria. Procedures for pre-analytical sample handling, biobanking, analyses and post-analytical interpretation of the results were intensively studied and optimised. A global quality control project was introduced to evaluate and monitor the inter-centre variability in measurements with the goal of harmonisation of results. Contexts of use and how to approach candidate biomarkers in biological specimens other than cerebrospinal fluid (CSF), e.g. blood, were precisely defined. Important development was achieved in neuroimaging techniques, including studies comparing amyloid-β positron emission tomography results to fluid-based modalities. Similarly, development in research laboratory technologies, such as ultra-sensitive methods, raises our hopes to further improve analytical and diagnostic accuracy of classic and novel candidate biomarkers. Synergistically, advancement in clinical trials of anti-dementia therapies energises and motivates the efforts to find and optimise the most reliable early diagnostic modalities. Finally, the first studies were published addressing the potential of cost-effectiveness of the biomarkers-based diagnosis of neurodegenerative disorders.

8 December 2020 in Frontiers in Global Women's Health
Verified
Journal Article
Open access
FTflorence Thibaut
florence Thibaut
PWPatricia J. M. van Wijngaarden-Cremers
Patricia J. M. van Wijngaarden-Cremers
Even if the fatality rate has been twice higher for men than for women, the Covid-19 pandemic has affected women more than men, both as frontline workers and at home. The aim of our article was to analyze the differences observed in mental health and violence between men and women in the COVID outbreak. For this purpose, we have used all papers available in PubMed between January and July 2020 as well as data from non-governmental associations. We have thus successively analyzed the situation of pregnancy during the pandemic; the specific psychological and psychiatric risks faced by women both as patients and as workers in the health sector, the increased risk of violence against women at home and at workplace and, finally the risk run by children within their families. In conclusion, research on the subject of mental health issues during the Covid-19 pandemic is still scarce, especially in women. We hope that this pandemic will help to recognize the major role of women at home and at the workplace.

30 June 2017 in Dialogues in clinical neuroscience
Verified
Journal Article
Open access
FTflorence Thibaut
florence Thibaut
Anxiety disorders are the most prevalent psychiatric disorders. There is a high comorbidity between anxiety (especially generalized anxiety disorders or panic disorders) and depressive disorders or between anxiety disorders, which renders treatment more complex. Current guidelines do not recommend benzodiazepines as first-line treatments due to their potential side effects. Selective serotonin reuptake inhibitors and selective serotonin norepinephrine reuptake inhibitors are recommended as first-line treatments. Psychotherapy, in association with pharmacotherapy, is associated with better efficacy. Finally, a bio-psycho-social model is hypothesized in anxiety disorders.

30 June 2020 in Dialogues in clinical neuroscience
Verified
Journal Article
Open access
MHMargret R. Hoehe
Margret R. Hoehe
FTflorence Thibaut
florence Thibaut
The digital revolution has changed, and continues to change, our world and our lives. Currently, major aspects of our lives have moved online due to the coronavirus pandemic, and social distancing has necessitated virtual togetherness. In a synopsis of 10 articles we present ample evidence that the use of digital technology may influence human brains and behavior in both negative and positive ways. For instance, brain imaging techniques show concrete morphological alterations in early childhood and during adolescence that are associated with intensive digital media use. Technology use apparently affects brain functions, for example visual perception, language, and cognition. Extensive studies could not confirm common concerns that excessive screen time is linked to mental health problems, or the deterioration of well-being. Nevertheless, it is important to use digital technology consciously, creatively, and sensibly to improve personal and professional relationships. Digital technology has great potential for mental health assessment and treatment, and the improvement of personal mental performance.

26 May 2020 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
FTflorence Thibaut
florence Thibaut
PCPaul Cosyns
Paul Cosyns
JFJohn Paul Fedoroff
John Paul Fedoroff
PBPeer Briken
Peer Briken
KGKris Goethals
Kris Goethals
TPThe Wfsbp Task Force On Paraphilias
The Wfsbp Task Force On Paraphilias
Objectives: The primary aim of these guidelines is to evaluate the role of pharmacological agents in the treatment and management of patients with paraphilic disorders, with a focus on the treatment of adult males. Because such treatments are not delivered in isolation, the role of specific psychotherapeutic interventions is also briefly covered. These guidelines are intended for use in clinical practice by clinicians who diagnose and treat patients, including sexual offenders, with paraphilic disorders. The aim of these guidelines is to bring together different views on the appropriate treatment of paraphilic disorders from experts representing different countries in order to aid physicians in clinical decisions and to improve the quality of care. Methods: An extensive literature search was conducted using the English-language-literature indexed on MEDLINE/PubMed (1990−2018 for SSRIs) (1969−2018 for hormonal treatments), supplemented by other sources, including published reviews. Results: Each treatment recommendation was evaluated and discussed with respect to the strength of evidence for its efficacy, safety, tolerability, and feasibility. The type of medication used depends on the severity of the paraphilic disorder and the respective risk of behaviour endangering others. GnRH analogue treatment constitutes the most relevant treatment for patients with severe paraphilic disorders. Conclusions: An algorithm is proposed with different levels of treatment for different categories of paraphilic disorders accompanied by different risk levels.

17 November 2022 in Dialogues in clinical neuroscience
Verified
Journal Article
Open access
DTDaniel Turner
Daniel Turner
PBPeer Briken
Peer Briken
JGJoshua Grubbs
Joshua Grubbs
LMLeo Malandain
Leo Malandain
GMGemma Mestre-Bach
Gemma Mestre-Bach
FTflorence Thibaut
florence Thibaut
The current guidelines aim to evaluate the role of pharmacological agents in the treatment of patients with compulsive sexual behaviour disorder (CSBD). They are intended for use in clinical practi...